Results 41 to 50 of about 6,114 (217)

Atrial Fibrillation Predicts Long-Term Outcome after Transcatheter Edge-to-Edge Mitral Valve Repair by MitraClip Implantation

Biomolecules, 2018
Background: Atrial fibrillation is common in patients with mitral regurgitation (MR) and has a negative impact on the clinical outcome of patients with valvular heart disease.
Mirjam Keßler, Alexander Pott, Elnura Mammadova, Julia Seeger, Jochen Wöhrle, Wolfgang Rottbauer, Sinisa Markovic   +6 more
doaj   +1 more source

Parametry badania echokardiograficznego pomocne w kwalifikacji do zabiegu MitraClip [PDF]

, 2016
Currently, the best method of treatment of mitral regurgitation is the surgical correction (valve repair or replacement). However, because of the coexisting comorbidities alternative therapies are sought.
Budnik, Monika; 1st Department of Cardiology Medical University of Warsaw 02-097 Warsaw, Poland
core   +1 more source

Complications following transcatheter edge-to-edge mitral valve repair: Personal experience and review of the literature

Cardiology Journal, 2023
Mitral valve dysfunction affects around 2% of the population and its incidence is still increasing, making it the second most common valvular heart disease, after aortic stenosis.
Dominik Maj, Karolina Jasińska-Gniadzik, Tomasz Kopiec, Małgorzata Wieteska, Aleksandra Gąsecka, Adam Rdzanek, Adriaan O. Kraaijeveld, Krzysztof Pujdak, Marcin Grabowski, Arkadiusz Pietrasik   +9 more
doaj   +1 more source

Sex-Specific Difference in Outcomes after Transcatheter Mitral Valve Repair with MitraClip Implantation: A Systematic Review and Meta-Analysis

Journal of Interventional Cardiology, 2022
Background. Implantation of the MitraClip is a safe and effective therapy for mitral valve repair in patients ineligible for surgery or at high risk of adverse surgical outcomes.
Fuqiang Sun, Honghao Liu, Qi Zhang, Jiawei Zhou, Haibo Zhan, Fanfan Lu   +5 more
doaj   +1 more source

Interventionelle Therapie der Mitralklappe: MitraClip® – Indikationen und Vorgehen 2017

, 2017
ZusammenfassungDie interventionelle Behandlung der Mitralklappeninsuffizienz mit dem MitraClip®-Verfahren ist mittlerweile eine etablierte Alternative für Hochrisikopatienten.
Jan Horstkotte, Peter Boekstegers
core   +1 more source

PASCAL mitral valve repair system versus MitraClip

, 2021
\(\bf Background\) The PASCAL system is a novel device for edge-to-edge treatment of mitral regurgitation (MR). The aim of this study was to compare the safety and efficacy of the PASCAL to the MitraClip system in a highly selected group of patients ...
Roder, Fabian (Dr.), Fortmeier, Vera (Dr. med.), Gerçek, Muhammed (Prof. Dr. med.), Rudolph, Volker (PD Dr. med.), Friedrichs, Kai (Dr. med.), Zittermann, Armin (Prof. Dr.), Rudolph, Tanja (Prof. Dr. med.)   +6 more
core   +1 more source

Mitral and Tricuspid Transcatheter Interventions Current Indications and Future Directions

Frontiers in Cardiovascular Medicine, 2020
Valvular heart disease is responsible for a high rate of morbidity and mortality, especially in the elderly population. With the emergence of new transcatheter treatment options, the therapeutic spectrum for patients with valvular heart disease has ...
Mirjam Gauri Winkel, Fabien Praz, Peter Wenaweser, Peter Wenaweser   +3 more
doaj   +1 more source

Diagram of the proposed mechanical effects of MitraClip application.

, 2019
The black arrows represent displacement of the posterior leaflet, lateral annulus and lateral sub-valvular LV wall caused by MitraClip application. The effects are to increase leaflet stress, decrease the septo-lateral annular dimension and stretch the ...
Liang Ge (541067), Yue Zhang (30585), Ashley E. Morgan (7485728), Robert A. Levine (4479625), Mark B. Ratcliffe (4479631), Chaya S. Moskowitz (7485734), Vicky Y. Wang (7485725), Mark D. Handschumacher (7485731), Julius M. Guccione (7485737), Jiwon Kim (573413), Jonathan W. Weinsaft (7485740)   +10 more
core   +1 more source

Is surgery the fair competitor for MitraClip?

, 2021
In the last decades, the overlapping areas of intervention between cardiac surgeons and interventional cardiologists are rocketing, especially in the field of treatment of heart valve disease.
Lorusso, R., Calafiore, A.M., Raviola, E., Guarracini, S., Di Mauro, M., Di Marco, M., Stefano Guarracini, Roberto Lorusso, Michele Di Mauro, Antonio M. Calafiore, Eliana Raviola, Massimo Di Marco   +11 more
core   +1 more source

Simultaneous endovascular "edge-to-edge" clipping of the mitral valve leaflets and closure of the left atrial appendage in a high surgical risk patient

Alʹmanah Kliničeskoj Mediciny, 2022
Mitral regurgitation is one of the most common valvular heart diseases, with the gold standard of its treatment being an open surgical intervention. However, it is not always performed in patients with a high surgical risk.
Sergey P. Semitko, Dzhamil A. Asadov, Anna N. Rogatova, Alexander V. Stepanov, Natalya S. Mesyats, Natalya L. Pak, Tamara S. Sandodze, Viktoria V. Fomenko, Imomali K. Kamolov, Andrey N. Pankov, Olga V. Zakharova, Alexey V. Azarov, Irina E. Chernysheva, David G. Ioseliani   +13 more
doaj   +1 more source